Physician profile
Muhammad Ali
NPI 1194162834
$566.22
in general payments reported to CMS, 2019-2025
8 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.78 · 2024: $420 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $180.74 | 2021-2024 | Strata |
| Alexion Pharmaceuticals, INC. | $147.87 | 2024-2025 | Koselugo, Ultomiris |
| Novocure INC. | $117.23 | 2024 | Optune |
| Averitas Pharma INC. | $49.25 | 2025 | Qutenza |
| Stryker Corporation | $19.01 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.96 | 2025 | Thinflap |
| Neurelis, INC. | $17.19 | 2025 | Valtoco |
| Integra Lifesciences Corporation | $15.97 | 2024 | Codman Certas, Codman Hakim, Cusa Clarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.